草药市场（按形态、植物来源、类型、适应症和分销管道划分）—2025-2032 年全球预测

预计到 2032 年草药市场规模将成长至 1,193.2 亿美元，复合年增长率为 9.68%。

主要市场统计数据
基准年2024年	569.4亿美元
预计2025年	621.9亿美元
预测年份：2032年	1193.2亿美元
复合年增长率（%）	9.68%

现代草药生态系统的权威指南，捕捉消费者需求的变化、科学检验趋势和相关人员的期望

现代草药领域正处于悠久传统与现代快速创新的交汇点。随着植物化学、临床检验和品质保证技术的进步，消费者对天然、预防和补充性医疗保健的兴趣日益成熟。因此，研究、生产、分销和临床实践领域的相关人员正在重新思考植物产品的开发、定位和监管方式。

本介绍概述了影响产品系列、采购决策和商业模式的关键动态。它强调了证据生成、安全和可追溯系统以及数位药房和订阅模式等零售创新在重新定义可及性方面所发挥的作用。重要的是，将传统药理学与植物药协同作用相结合的混合产品的兴起，正在改变临床医生和消费者评估疗效和风险的方式。

本节从相关人员合作的观点，阐述了监管机构、付款人和从业人员如何日益关注标准化品质、可重复剂量和透明的供应链。此外，本节还概述了眼光敏锐的消费者不断变化的期望，他们要求获得永续性证据和检验的功效数据。这些因素的共同作用，为寻求在这个快速发展的领域负责任地扩展业务的组织带来了机会，也带来了复杂性。

结构创新、监管加强和数位化加速的整合从根本上重塑了产品开发、采购和商业化的动态。

过去五年，草药产业格局发生了显着变化，从生产到病患疗效都发生了变化。分析化学和基因组学的进步改进了物种鑑定和杂质检测，使製造商能够提供更一致、更可预测的产品。同时，数位健康平台和远端医疗的发展降低了资讯和分销壁垒，提高了对临床证据和安全数据的期望，同时加速了直接面向消费者的销售管道的发展。

监管生态系统也在同步调整，当局强调良好生产规范 (GMP)、性能记录和不利事件报告。监管力度的加强，加上消费者对永续性的需求，正在推动与供应商建立伙伴关係关係的投资，这些供应商优先考虑可追溯的供应链、负责任的采收和长期的资源管理。从微胶囊萃取物到经皮凝胶，剂型和给药系统的创新正在改变产品开发的重点，并开闢新的治疗领域。

同时，商业化进程也变得更加协作，契约製造和原料专家与品牌商携手合作，以加快产品上市速度，并助力小型创新企业实现规模化发展。这种转变反映了更广泛的产业成熟度，其中科学严谨性、数位化覆盖率和供应链完整性共同决定了竞争差异化和长期生存能力。

对 2025 年美国关税如何刺激整个价值链采购多样化、营运弹性和监管合规性的投资进行现实分析。

2025年美国新关税的实施，将对整个草药产业的植物供应链、筹资策略和商业性定位产生多方面的影响。某些植物原料和成品製​​剂的进口关税促使企业重新评估供应商组合，鼓励采购团队实现采购区域多元化，并与直接供应商建立更紧密的关係，以降低单一产地风险。随着企业不断适应新形势，许多企业优先选择拥有强大追溯系统和垂直整合能力的供应商，以缓解关税引发的波动。

关税压力也影响配方和包装的选择，产品开发人员力求优化投入清单和包装空间，以限制跨国成本。面对不断上升的到岸成本，製造商采取了一系列应对措施，包括提高营运效率、调整物流路线以及选择性地将成本转嫁给贸易伙伴。对于某些品牌而言，这意味着将通路投资重点转向利润率更高的直销管道，从而缩短促销週期并更好地管理价格弹性。

关税不仅加速了直接的商业性调整，也加速了策略讨论，包括关键生产过程的本土化、区域製造能力的投资以及低关税地区供应商发展项目的深化。这些调整正在推动从交易型采购向发展供应商生态系统的转变，其中长期伙伴关係、技术合作以及在品质保证方面的共用对于韧性至关重要。同时，合规团队正在增加对贸易分类专业知识和原产地检验的投资，以确保关税处理得到适当应用，从而减少意外的成本流失和声誉风险。

综合细分洞察，将产品形态、植物来源、产品类型、治疗适应症和通路动态与策略组合决策连结起来

细分市场为确定产品策略、研发重点和通路投资优先顺序提供了策略视角。乳膏和软膏、精油、液体萃取物、粉剂、糖浆、片剂和胶囊、茶剂和汤剂都需要配方、稳定性和合规性方面的考量，从而影响生产和储存策略。除了剂型选择外，植物来源也是决定性因素。树皮、花朵、果实和种子、叶子和根的活性成分、采收週期和永续性限制各不相同。因此，植物的选择不仅决定了治疗目的，也决定了供应风险和可追溯性要求。

按产品类型细分，产品定位和商业化路径也有所不同。膳食补充剂和草本机能性食品涵盖营养和健康定位，并注重消费者信任和科学基础。草药需要更高水准的临床证据和法规遵循性，这会影响开发时间表和经销伙伴。按适应症细分，涵盖心血管健康、消化器官系统疾病、整体健康和免疫力增强、肝肾疾病、精神健康、呼吸系统疾病、性健康和生殖问题、皮肤疾病等，指南了研发优先事项和索赔策略。

分销管道塑造获取途径和品牌体验：阿育吠陀诊所和传统治疗师提供临床信誉和文化信任，直销利用个人网络和体验式营销，健康保健商店和医院/药房提供精心策划的临床接触点，在线药房/电商实现规模化和数据主导的精准定位，超级市场/大卖场提供广泛的知名度和便利性。了解这些细分市场如何相互作用，可以帮助您了解植物来源的特定剂型如何与特定适应症和管道的监管要求相符，从而使您能够优化产品组合，实现商业性可行性和合规性。

区域比较分析重点介绍美洲、欧洲、中东和非洲以及亚太地区的草药产品优势、监管差异和供应链影响

区域动态对整个草药生态系统的供应链、监管方式和消费者偏好有着强大的影响。在美洲，成熟的零售基础设施和消费者对循证天然健康解决方案日益增长的兴趣，为优质配方和临床导向的补充剂创造了有利条件。跨境贸易协定和关税制度进一步影响了筹资策略，迫使企业在成本和特定植物物种的取得之间取得平衡。

欧洲、中东和非洲是一个多元化的地区，监管环境、传统药物的文化接受度以及生产能力水平存在差异，因此需要采取细緻入微的市场准入策略。在欧洲部分地区，强有力的法律规范和消费者保护框架要求严格的品质系统和清晰的功效证明；而传统医疗实践成熟的地区则提供了替代管道，以及与传统治疗师和当地执业医师的合作模式。

亚太地区仍然是重要的供应和创新中心，拥有丰富的植物多样性、深厚的传统知识体系和大规模生产。当地消费者对草药的熟悉度支持了产品的快速普及，而对标准化萃取技术和符合GMP标准的设施的投资则提升了出口能力。在全部区域，原材料禀赋和监管完善程度等比较优势正在推动着生产地点、研发合作和通路优先排序的策略决策。

洞察竞争动态：成分专家、契约製造、数位原生品牌和专家网路如何塑造整合和差异化

竞争格局由各种能力互补的参与者组成，从成分专家和契约製造，到数位原民品牌和由从业者主导的公司。提供经过验证的萃取物和品管服务的成分供应商已成为寻求缩短配方时间并确保活性成分一致性的品牌的策略合作伙伴。契约製造製造商和自有品牌合作伙伴使新兴品牌能够扩大规模，使他们能够将资源集中在行销、宣传验证和通路开发。

数位优先的消费品牌透过直接互动、数据主导的个人化和敏捷的产品发布实现差异化，并通常利用订阅模式来提升终身价值。传统的医生和诊所网路在重视文化信任和麵对面诊断的领域仍然具有影响力，并创造了将临床检验与社区倡导相结合的混合商业化模式。在整个产业中，我们看到越来越多的策略联盟和併购活动旨在整合供应链、获取技术力并扩大地理覆盖范围。

品质保证和合规能力对竞争定位日益重要。投资可追溯性、第三方侦测和透明标籤的公司正在赢得消费者和机构投资者的信任。同时，与科学主导的组织和草药专家的伙伴关係正在推动更稳健的临床项目，从而提升产品合法性并扩大其在传统医疗保健途径中的接受度。

为高阶主管提供以行动为导向的策略重点，以加强其供应商生态系统、加速证据计划、优化管道并提高製造敏捷性

行业领导者应采取一系列优先行动，以平衡商业性敏捷性和长期韧性。首先，建构供应商生态系统，强调在多样性、可追溯性和品质保证方面的共同投资，而不是依赖单一来源的采购模式。加强采购地区的实地伙伴关係关係，并投资于供应商能力建设，可减少关税和气候相关衝击的影响，同时提升永续性资质。

第二，加速与目标适应症和通路相符的证据产生项目。对于消费者健康产品，真实世界证据和经过验证的生物标记可以支持可靠的定位。第三，优化通路组合，将投资导向高价值接点。直接管道和透过临床医生分销可以更好地控制利润和获取数据，从而实现更有针对性的产品迭代。

第四，透过地理多元化製造和模组化生产能力提升营运弹性，以便根据贸易和监管变化快速进行重新配置。最后，将监管和贸易分类专业知识纳入商业规划，预测跨境成本风险，并充分利用可用的优惠贸易协定。这些措施相结合，将形成一种协调一致的方案，以缓解短期衝击并建立可持续的竞争优势。

严格的混合方法研究框架结合了初步访谈、文件分析、供应链追踪和专家检验，确保了可靠且可操作的研究结果

研究途径结合了多种混合方法，旨在确保研究的有效性、可靠性和实用性。主要研究包括结构化访谈和与不同相关人员的深入讨论，这些利害关係人包括产品开发人员、供应链经理、法规事务专家、临床医生和通路合作伙伴。此外，还进行了现场审查和虚拟设施审核，以评估种植方法、加工能力和品管程序。

二次研究整合了监管文件、同行评审文献和技术标准，以详细描绘合规期望和不断发展的最佳实践。供应链追踪利用原产地检验工具和证书审查来评估来源并识别浓缩风险。采用定性综合方法，协调相关人员的不同观点，突出可操作的主题，并透过内部三角测量和文件证据来确保一致性并减少偏见。

调查方法提供了访谈通讯协定、选择标准和检验程序。研究结果与专家进行了反覆讨论，以确保技术准确性并检验其战略和营运意义。这种多层次的方法得出了基于证据的结论，可直接应用于商业性和技术决策者。

风险、韧性和机会的简明综合，展示了科学检验、可追溯性和负责任的商业化将如何决定未来的赢家

不断发展的草药产业既带来机会，也承担责任。分析和临床方法的进步，加上数位化分销和日益增长的监管要求，正在提升整个价值链的标准。投资于透明供应链、健全的品质系统和可靠的证据产生的组织，将最有能力应对不断变化的消费者偏好和日益严格的监管审查。

韧性取决于策略性采购多元化、选择性在岸化和本地能力建设，以及快速调整营运以应对贸易或环境变化的能力。同样重要的是，透过透明的沟通、第三方检验以及有针对性的临床项目来建立信任，这些项目不仅能证实相关声明，还能保障消费者安全。领导者迫切需要将商业性抱负与永续采购和科学严谨性相结合，以确保长期的品牌诚信和合规性。

总而言之，该行业正在从分散化走向专业化，科学检验、供应链完整性和负责任的商业化将共同决定哪些产品和公司将在未来几年成功扩大规模。

目录

第一章：前言

第二章调查方法

第三章执行摘要

第四章 市场概况

第五章 市场洞察

• 将传统草药配方融入主流保健产品
• 基于基因组和微生物组洞察的个人化草药补充疗法的兴起
• 药用植物的永续野生采收和再生种植
• 扩展远端医疗平台，提供虚拟咨询和草药处方服务
• 开发奈米乳液和脂质体递送系统以提高草药化合物的生物有效性
• 製药和营养补充剂公司合作标准化草药萃取物的品质指标
• 适应原蘑菇混合物在压力管理和免疫支持的健康常规中越来越受欢迎

第六章：2025年美国关税的累积影响

第七章：人工智慧的累积影响，2025年

8. 草药市场（依形式）

• 乳膏和软膏
• 精油
• 液体萃取物
• 粉末
• 糖浆
• 片剂和胶囊
• 茶和凉茶

9. 草药市场（植物来源）

• 吠
• 花
• 水果和种子
• 叶子
• 根

第十章 草药市场（按类型）

• 草本美容产品/化妆品
• 草本膳食补充剂
• 草本机能性食品
• 草药

第 11 章 草药市场（依适应症）

• 心血管健康
• 消化系统疾病
• 改善整体健康和免疫力
• 肝肾疾病
• 心理健康
• 呼吸系统疾病
• 性健康和生殖问题
• 皮肤病

第 12 章。草药市场（按分销管道）

• 阿育吠陀诊所和传统治疗师
• 直销
• 健康与保健商店
• 医院和药房
• 网路药局/电子商务
• 超级市场/大卖场

第十三章 草药市场（按地区）

• 美洲
  • 北美洲
  • 拉丁美洲
• 欧洲、中东和非洲
  • 欧洲
  • 中东
  • 非洲
• 亚太地区

第十四章 草药市场（依类别）

• ASEAN
• GCC
• EU
• BRICS
• G7
• NATO

第十五章 各国草药市场

• 美国
• 加拿大
• 墨西哥
• 巴西
• 英国
• 德国
• 法国
• 俄罗斯
• 义大利
• 西班牙
• 中国
• 印度
• 日本
• 澳洲
• 韩国

第十六章竞争格局

• 2024年市占率分析
• 2024年FPNV定位矩阵
• 竞争分析
  • Ayush Herbs herbal products Company
  • Baidyanath Ayurved
  • Bionorica SE
  • Blackmores Limited
  • Cultivator Natural Products Pvt. Ltd.
  • DABUR Limited
  • Emami Limited
  • Gaia Herbs, Inc.
  • Herbal Hills
  • Himalaya Global Holdings Ltd.

The Herbal Medicine Market is projected to grow by USD 119.32 billion at a CAGR of 9.68% by 2032.

KEY MARKET STATISTICS
Base Year [2024]	USD 56.94 billion
Estimated Year [2025]	USD 62.19 billion
Forecast Year [2032]	USD 119.32 billion
CAGR (%)	9.68%

An authoritative orientation to the modern herbal medicine ecosystem, capturing consumer demand shifts, scientific validation trends, and stakeholder expectations

The contemporary herbal medicine landscape sits at the intersection of centuries-old traditions and rapid modern innovation. Consumer interest in natural, preventive, and complementary healthcare options has matured alongside advances in phytochemistry, clinical validation, and quality assurance practices. As a result, stakeholders across research, manufacturing, distribution, and clinical practice are recalibrating how botanical products are developed, positioned, and regulated.

This introduction frames the critical dynamics shaping product portfolios, sourcing decisions, and commercial models. It highlights the roles of evidence generation, safety and traceability systems, and retail innovations such as digital pharmacies and subscription models that are redefining accessibility. Importantly, the rise of hybrid offerings that blend conventional pharmacology with botanical synergies is changing how clinicians and consumers evaluate efficacy and risk.

Through a lens of stakeholder alignment, the section contextualizes how regulators, payers, and practitioners are increasingly focused on standardized quality, reproducible dosing, and transparent supply chains. It also outlines the evolving expectations of discerning consumers who demand sustainability credentials and verifiable efficacy data. Taken together, these forces create both opportunity and complexity for organizations seeking to scale responsibly in this rapidly evolving sector.

A synthesis of structural innovations, regulatory tightening, and digital acceleration that are fundamentally reshaping product development, sourcing, and commercialization dynamics

The past five years have seen transformative shifts that are remapping the herbal medicine landscape from production to patient outcomes. Advances in analytical chemistry and genomics have improved species identification and adulteration detection, enabling manufacturers to deliver more consistent and predictable products. Simultaneously, the growth of digital health platforms and telemedicine has lowered barriers to information and distribution, accelerating direct-to-consumer channels while elevating expectations for clinical evidence and safety data.

Regulatory ecosystems are adapting in parallel, with authorities emphasizing good manufacturing practices, provenance documentation, and adverse-event reporting. This regulatory tightening-coupled with consumer demand for sustainability-has driven investments in traceable supply chains, responsible harvesting, and supplier partnerships that prioritize long-term resource stewardship. Innovation in dosing formats and delivery systems, ranging from microencapsulated extracts to transdermal gels, is reshaping product development priorities and opening new therapeutic niches.

At the same time, commercialization is increasingly collaborative: contract manufacturing and ingredient-specialist firms are partnering with brand owners to accelerate time-to-market while enabling smaller innovators to scale. These shifts reflect a broader industry maturation where scientific rigour, digital reach, and supply chain integrity jointly determine competitive differentiation and long-term viability.

A pragmatic analysis of how 2025 United States tariff measures have catalyzed sourcing diversification, operational resilience, and regulatory-compliance investments across the value chain

The introduction of new tariffs by the United States in 2025 has had a multifaceted effect on botanical supply chains, procurement strategies, and commercial positioning across the herbal medicine sector. Import duties on certain botanical inputs and finished formulations have prompted a re-evaluation of supplier portfolios, encouraging procurement teams to diversify sourcing geographies and to build closer direct-supplier relationships that reduce exposure to single-origin risk. As firms adapt, many are prioritizing suppliers with strong traceability systems and vertically integrated capabilities to mitigate tariff-driven volatility.

Tariff pressure has also influenced formulation and packaging choices, with product developers seeking to optimize input lists and packaging footprints to limit cross-border cost exposure. Manufacturers facing higher landed costs have responded through a combination of operational efficiency programs, changed logistics routing, and selective cost pass-through to trade partners. For some brands, this has meant compressing promotional cycles and re-prioritizing channel investments toward higher-margin direct channels where pricing elasticity can be better managed.

Beyond immediate commercial adjustments, tariffs have accelerated strategic conversations about onshoring critical production steps, investing in regional manufacturing capacity, and deepening supplier development programs in lower-tariff jurisdictions. These adaptations are prompting a shift from transactional sourcing toward supplier ecosystem development, where long-term partnerships, technical collaboration, and shared investments in quality assurance become integral to resilience. At the same time, compliance teams are investing more in trade classification expertise and origin verification to ensure tariff treatments are properly applied, thereby reducing unexpected cost leakage and reputational risk.

Integrated segmentation insights that connect product form, botanical origin, product type, therapeutic indication, and channel dynamics to strategic portfolio decisions

Segmentation provides the strategic lens through which product strategies, R&D focus, and channel investments are prioritized. Based on form, stakeholders are rethinking how consumers prefer to receive herbal benefits, with Creams & Ointments, Essential Oils, Liquid Extracts, Powders, Syrups, Tablets & Capsules, and Teas & Infusions each presenting distinct formulation, stability, and compliance considerations that influence manufacturing and shelf-life strategies. Parallel to form choices, botanical origin is a decisive factor: Bark, Flowers, Fruits & Seeds, Leaves, and Roots vary in active constituent profiles, harvest cycles, and sustainability constraints; botanical selection therefore determines not only therapeutic intent but also supply risk and traceability requirements.

Type-based segmentation differentiates product positioning and commercialization routes. Herbal Beauty Products and Cosmetics demand high sensory quality and regulatory labeling that aligns with cosmetic standards, while Herbal Dietary Supplements and Herbal Functional Foods straddle nutrition and health positioning with an emphasis on consumer trust and scientific substantiation. Herbal Pharmaceutical Products require a higher threshold of clinical evidence and regulatory compliance, influencing development timelines and distribution partnerships. Indication-driven segmentation-spanning Cardiovascular Health, Digestive Disorders, General Wellness & Immunity Boosting, Liver & Kidney Disorders, Mental Health, Respiratory Conditions, Sexual Health & Reproductive Issues, and Skin Disorders-guides R&D prioritization and claims strategy, with some indications more amenable to evidence generation than others.

Distribution channels shape access and brand experience. Ayurvedic Clinics & Traditional Healers offer clinical credibility and culturally embedded trust; Direct Selling leverages personal networks and experiential marketing; Health & Wellness Stores and Hospital & Retail Pharmacies provide curated, clinical-facing touchpoints; Online Pharmacies / E-commerce enable scale and data-driven targeting; while Supermarkets / Hypermarkets deliver broad visibility and convenience. Understanding how these segments interact-how a particular form sourced from specific botanical origins aligns with regulatory expectations for a given indication and channel-enables portfolio optimization that is both commercially viable and compliant.

Comparative regional analysis highlighting the Americas, Europe Middle East & Africa, and Asia-Pacific strengths, regulatory variations, and supply chain implications for herbal products

Regional dynamics exert a powerful influence on supply chains, regulatory approaches, and consumer preferences across the herbal medicine ecosystem. In the Americas, established retail infrastructures and growing consumer interest in evidence-based natural health solutions create fertile conditions for premiumized formulations and clinically oriented supplements, while domestic cultivation and processing initiatives seek to reduce import dependency and improve provenance transparency. Cross-border trade agreements and tariff regimes further shape sourcing strategies, with companies balancing costs against access to specific botanical species.

Europe, Middle East & Africa presents a heterogeneous landscape where regulatory stringency, cultural acceptance of traditional medicine, and varying levels of manufacturing capacity demand nuanced market entry approaches. In parts of Europe, strong regulatory oversight and consumer protection frameworks necessitate rigorous quality systems and clear claims substantiation, whereas regions with entrenched traditional medicine practices provide alternative channels and partnership models with traditional healers and community practitioners.

The Asia-Pacific region remains a critical supplier and innovation hub, combining rich botanical biodiversity with deep traditional knowledge systems and significant manufacturing scale. Local consumer familiarity with herbal modalities supports rapid product adoption, while investments in standardized extraction technologies and GMP-compliant facilities are elevating export readiness. Across these regions, comparative strengths-ranging from raw material endowments to regulatory sophistication-inform strategic decisions about production location, R&D collaboration, and channel prioritization.

Insightful appraisal of competitive dynamics showing how ingredient specialists, contract manufacturers, digital-native brands, and practitioner networks are shaping consolidation and differentiation

The competitive landscape comprises diverse players with complementary capabilities, ranging from ingredient specialists and contract manufacturers to digitally native brands and practitioner-led enterprises. Ingredient suppliers that provide validated extracts and quality control services have become strategic partners for brands seeking to accelerate formulation timelines while ensuring consistent active profiles. Contract manufacturers and private-label partners enable scale for emerging brands, allowing them to focus resources on marketing, claims substantiation, and channel development.

Digital-first consumer brands are differentiating through direct engagement, data-driven personalization, and agile product launches, often using subscription models to enhance lifetime value. Traditional practitioners and clinic networks remain influential in segments where cultural trust and in-person diagnosis are important, creating hybrid commercialization models that blend clinical validation with community endorsement. Across the industry, there is growing evidence of strategic alliances and M&A activity aimed at consolidating supply chains, acquiring technical capabilities, and expanding geographic reach.

Quality assurance and regulatory compliance functions are increasingly central to competitive positioning. Firms investing in traceability, third-party testing, and transparent labeling are gaining credibility among both consumers and institutional buyers. At the same time, partnerships between science-led organizations and herbal experts are enabling more robust clinical programs that enhance product legitimacy and broaden acceptance within conventional healthcare pathways.

Action-oriented strategic priorities for executives to strengthen supplier ecosystems, accelerate evidence programs, optimize channels, and enhance manufacturing agility

Industry leaders should pursue a clear set of prioritized actions that balance commercial agility with long-term resilience. First, build supplier ecosystems that emphasize diversity, traceability, and co-investment in quality assurance rather than relying on single-source procurement models. Strengthening on-the-ground partnerships in sourcing regions and investing in supplier capacity development will reduce exposure to tariff and climate-related shocks while improving sustainability credentials.

Second, accelerate evidence-generation programs that align with target indications and distribution channels. For consumer-facing wellness products, pragmatic real-world evidence and validated biomarkers can support credible positioning, while for pharmaceutical-grade products, more rigorous clinical pathways should be pursued. Third, optimize channel mix by reallocating investment toward high-value touchpoints; direct channels and clinician-mediated distribution can offer better margin control and data capture, enabling more targeted product iterations.

Fourth, enhance operational flexibility through geographic manufacturing diversification and modular production capabilities that allow rapid reconfiguration in response to trade or regulatory shifts. Finally, embed regulatory and trade-classification expertise into commercial planning to anticipate cross-border cost exposure and to exploit preferential trade arrangements where available. Taken together, these steps create a cohesive approach to mitigate near-term shocks and to build durable competitive advantage.

A rigorous mixed-methods research framework combining primary interviews, documentary analysis, supply chain tracing, and expert validation to ensure credible and actionable findings

The research approach combines mixed-methods techniques designed to ensure validity, credibility, and practical applicability. Primary research included structured interviews and in-depth discussions with a diverse set of stakeholders such as product developers, supply-chain managers, regulatory affairs specialists, clinical practitioners, and channel partners. These conversations were complemented by site-level reviews and virtual facility audits to assess cultivation practices, processing capabilities, and quality-control procedures.

Secondary research synthesized regulatory documents, peer-reviewed literature, and technical standards to construct a detailed picture of compliance expectations and evolving best practices. Supply chain tracing used origin verification tools and certificate review to evaluate provenance and to identify concentration risks. Qualitative synthesis methods were applied to reconcile differing stakeholder perspectives and to surface actionable themes, while internal triangulation against documentary evidence ensured consistency and reduced bias.

Throughout the process, emphasis was placed on transparency: methodology appendices document interview protocols, selection criteria, and validation steps. Findings were iteratively reviewed with subject-matter experts to ensure technical accuracy and to validate implications for strategy and operations. This multi-layered approach supports conclusions that are both evidence-based and directly usable by commercial and technical decision-makers.

A concise synthesis of risk, resilience, and opportunity showing how scientific validation, traceability, and responsible commercialization will determine future winners

The evolving herbal medicine sector presents a blend of opportunity and responsibility. Advances in analytical and clinical methodologies, combined with digital distribution and heightened regulatory expectations, are elevating standards across the value chain. Organizations that invest in transparent supply chains, robust quality systems, and credible evidence generation will be best positioned to capitalize on shifting consumer preferences and tighter regulatory scrutiny.

Resilience will depend on strategic diversification of sourcing, selective onshoring or regional capacity development, and the ability to rapidly reconfigure operations in response to trade or environmental disruptions. Equally important is the cultivation of trust through transparent communication, third-party verification, and targeted clinical programs that substantiate claims while protecting consumer safety. For leaders, the imperative is to align commercial ambitions with sustainable procurement and scientific rigor, thereby ensuring long-term brand integrity and regulatory compliance.

In sum, the sector is moving from fragmentation toward professionalization, where scientific validation, supply chain integrity, and responsible commercialization jointly determine which products and companies will scale successfully in the coming years.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Integration of traditional Chinese herbal formulas into mainstream wellness products
• 5.2. Rise of personalized herbal supplement regimens driven by genomic and microbiome insights
• 5.3. Adoption of sustainable wildcrafting and regenerative farming practices for medicinal botanicals
• 5.4. Expansion of telehealth platforms providing virtual consultation and herbal prescription services
• 5.5. Development of nanoemulsion and liposomal delivery systems to enhance herbal compound bioavailability
• 5.6. Collaboration between pharmaceutical and nutraceutical companies to standardize herbal extract quality metrics
• 5.7. Surge in popularity of adaptogenic mushroom blends for stress management and immune support in wellness routines

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Herbal Medicine Market, by Form

• 8.1. Creams & Ointments
• 8.2. Essential Oils
• 8.3. Liquid Extracts
• 8.4. Powders
• 8.5. Syrups
• 8.6. Tablets & Capsules
• 8.7. Teas & Infusions

9. Herbal Medicine Market, by Botanical Origin

• 9.1. Bark
• 9.2. Flowers
• 9.3. Fruits & Seeds
• 9.4. Leaves
• 9.5. Roots

10. Herbal Medicine Market, by Type

• 10.1. Herbal Beauty Products / Cosmetics
• 10.2. Herbal Dietary Supplements
• 10.3. Herbal Functional Foods
• 10.4. Herbal Pharmaceutical Products

11. Herbal Medicine Market, by Indication

• 11.1. Cardiovascular Health
• 11.2. Digestive Disorders
• 11.3. General Wellness & Immunity Boosting
• 11.4. Liver & Kidney Disorders
• 11.5. Mental Health
• 11.6. Respiratory Conditions
• 11.7. Sexual Health & Reproductive Issues
• 11.8. Skin Disorders

12. Herbal Medicine Market, by Distribution Channel

• 12.1. Ayurvedic Clinics & Traditional Healers
• 12.2. Direct Selling
• 12.3. Health & Wellness Stores
• 12.4. Hospital & Retail Pharmacies
• 12.5. Online Pharmacies / E-commerce
• 12.6. Supermarkets / Hypermarkets

13. Herbal Medicine Market, by Region

• 13.1. Americas
  • 13.1.1. North America
  • 13.1.2. Latin America
• 13.2. Europe, Middle East & Africa
  • 13.2.1. Europe
  • 13.2.2. Middle East
  • 13.2.3. Africa
• 13.3. Asia-Pacific

14. Herbal Medicine Market, by Group

• 14.1. ASEAN
• 14.2. GCC
• 14.3. European Union
• 14.4. BRICS
• 14.5. G7
• 14.6. NATO

15. Herbal Medicine Market, by Country

• 15.1. United States
• 15.2. Canada
• 15.3. Mexico
• 15.4. Brazil
• 15.5. United Kingdom
• 15.6. Germany
• 15.7. France
• 15.8. Russia
• 15.9. Italy
• 15.10. Spain
• 15.11. China
• 15.12. India
• 15.13. Japan
• 15.14. Australia
• 15.15. South Korea

16. Competitive Landscape

• 16.1. Market Share Analysis, 2024
• 16.2. FPNV Positioning Matrix, 2024
• 16.3. Competitive Analysis
  • 16.3.1. Ayush Herbs herbal products Company
  • 16.3.2. Baidyanath Ayurved
  • 16.3.3. Bionorica SE
  • 16.3.4. Blackmores Limited
  • 16.3.5. Cultivator Natural Products Pvt. Ltd.
  • 16.3.6. DABUR Limited
  • 16.3.7. Emami Limited
  • 16.3.8. Gaia Herbs, Inc.
  • 16.3.9. Herbal Hills
  • 16.3.10. Himalaya Global Holdings Ltd.

LIST OF FIGURES

• FIGURE 1. GLOBAL HERBAL MEDICINE MARKET SIZE, 2018-2032 (USD MILLION)
• FIGURE 2. GLOBAL HERBAL MEDICINE MARKET SIZE, BY FORM, 2024 VS 2032 (%)
• FIGURE 3. GLOBAL HERBAL MEDICINE MARKET SIZE, BY FORM, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 4. GLOBAL HERBAL MEDICINE MARKET SIZE, BY BOTANICAL ORIGIN, 2024 VS 2032 (%)
• FIGURE 5. GLOBAL HERBAL MEDICINE MARKET SIZE, BY BOTANICAL ORIGIN, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 6. GLOBAL HERBAL MEDICINE MARKET SIZE, BY TYPE, 2024 VS 2032 (%)
• FIGURE 7. GLOBAL HERBAL MEDICINE MARKET SIZE, BY TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 8. GLOBAL HERBAL MEDICINE MARKET SIZE, BY INDICATION, 2024 VS 2032 (%)
• FIGURE 9. GLOBAL HERBAL MEDICINE MARKET SIZE, BY INDICATION, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 10. GLOBAL HERBAL MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2032 (%)
• FIGURE 11. GLOBAL HERBAL MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 12. GLOBAL HERBAL MEDICINE MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 13. AMERICAS HERBAL MEDICINE MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 14. NORTH AMERICA HERBAL MEDICINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 15. LATIN AMERICA HERBAL MEDICINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 16. EUROPE, MIDDLE EAST & AFRICA HERBAL MEDICINE MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 17. EUROPE HERBAL MEDICINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 18. MIDDLE EAST HERBAL MEDICINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 19. AFRICA HERBAL MEDICINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 20. ASIA-PACIFIC HERBAL MEDICINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 21. GLOBAL HERBAL MEDICINE MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 22. ASEAN HERBAL MEDICINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 23. GCC HERBAL MEDICINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 24. EUROPEAN UNION HERBAL MEDICINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 25. BRICS HERBAL MEDICINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 26. G7 HERBAL MEDICINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 27. NATO HERBAL MEDICINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 28. GLOBAL HERBAL MEDICINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 29. HERBAL MEDICINE MARKET SHARE, BY KEY PLAYER, 2024
• FIGURE 30. HERBAL MEDICINE MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

• TABLE 1. HERBAL MEDICINE MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
• TABLE 3. GLOBAL HERBAL MEDICINE MARKET SIZE, 2018-2024 (USD MILLION)
• TABLE 4. GLOBAL HERBAL MEDICINE MARKET SIZE, 2025-2032 (USD MILLION)
• TABLE 5. GLOBAL HERBAL MEDICINE MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
• TABLE 6. GLOBAL HERBAL MEDICINE MARKET SIZE, BY FORM, 2025-2032 (USD MILLION)
• TABLE 7. GLOBAL HERBAL MEDICINE MARKET SIZE, BY CREAMS & OINTMENTS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 8. GLOBAL HERBAL MEDICINE MARKET SIZE, BY CREAMS & OINTMENTS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 9. GLOBAL HERBAL MEDICINE MARKET SIZE, BY CREAMS & OINTMENTS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 10. GLOBAL HERBAL MEDICINE MARKET SIZE, BY CREAMS & OINTMENTS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 11. GLOBAL HERBAL MEDICINE MARKET SIZE, BY CREAMS & OINTMENTS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 12. GLOBAL HERBAL MEDICINE MARKET SIZE, BY CREAMS & OINTMENTS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 13. GLOBAL HERBAL MEDICINE MARKET SIZE, BY ESSENTIAL OILS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 14. GLOBAL HERBAL MEDICINE MARKET SIZE, BY ESSENTIAL OILS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 15. GLOBAL HERBAL MEDICINE MARKET SIZE, BY ESSENTIAL OILS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 16. GLOBAL HERBAL MEDICINE MARKET SIZE, BY ESSENTIAL OILS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 17. GLOBAL HERBAL MEDICINE MARKET SIZE, BY ESSENTIAL OILS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 18. GLOBAL HERBAL MEDICINE MARKET SIZE, BY ESSENTIAL OILS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 19. GLOBAL HERBAL MEDICINE MARKET SIZE, BY LIQUID EXTRACTS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 20. GLOBAL HERBAL MEDICINE MARKET SIZE, BY LIQUID EXTRACTS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 21. GLOBAL HERBAL MEDICINE MARKET SIZE, BY LIQUID EXTRACTS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 22. GLOBAL HERBAL MEDICINE MARKET SIZE, BY LIQUID EXTRACTS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 23. GLOBAL HERBAL MEDICINE MARKET SIZE, BY LIQUID EXTRACTS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 24. GLOBAL HERBAL MEDICINE MARKET SIZE, BY LIQUID EXTRACTS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 25. GLOBAL HERBAL MEDICINE MARKET SIZE, BY POWDERS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 26. GLOBAL HERBAL MEDICINE MARKET SIZE, BY POWDERS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 27. GLOBAL HERBAL MEDICINE MARKET SIZE, BY POWDERS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 28. GLOBAL HERBAL MEDICINE MARKET SIZE, BY POWDERS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 29. GLOBAL HERBAL MEDICINE MARKET SIZE, BY POWDERS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 30. GLOBAL HERBAL MEDICINE MARKET SIZE, BY POWDERS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 31. GLOBAL HERBAL MEDICINE MARKET SIZE, BY SYRUPS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 32. GLOBAL HERBAL MEDICINE MARKET SIZE, BY SYRUPS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 33. GLOBAL HERBAL MEDICINE MARKET SIZE, BY SYRUPS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 34. GLOBAL HERBAL MEDICINE MARKET SIZE, BY SYRUPS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 35. GLOBAL HERBAL MEDICINE MARKET SIZE, BY SYRUPS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 36. GLOBAL HERBAL MEDICINE MARKET SIZE, BY SYRUPS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 37. GLOBAL HERBAL MEDICINE MARKET SIZE, BY TABLETS & CAPSULES, BY REGION, 2018-2024 (USD MILLION)
• TABLE 38. GLOBAL HERBAL MEDICINE MARKET SIZE, BY TABLETS & CAPSULES, BY REGION, 2025-2032 (USD MILLION)
• TABLE 39. GLOBAL HERBAL MEDICINE MARKET SIZE, BY TABLETS & CAPSULES, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 40. GLOBAL HERBAL MEDICINE MARKET SIZE, BY TABLETS & CAPSULES, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 41. GLOBAL HERBAL MEDICINE MARKET SIZE, BY TABLETS & CAPSULES, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 42. GLOBAL HERBAL MEDICINE MARKET SIZE, BY TABLETS & CAPSULES, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 43. GLOBAL HERBAL MEDICINE MARKET SIZE, BY TEAS & INFUSIONS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 44. GLOBAL HERBAL MEDICINE MARKET SIZE, BY TEAS & INFUSIONS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 45. GLOBAL HERBAL MEDICINE MARKET SIZE, BY TEAS & INFUSIONS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 46. GLOBAL HERBAL MEDICINE MARKET SIZE, BY TEAS & INFUSIONS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 47. GLOBAL HERBAL MEDICINE MARKET SIZE, BY TEAS & INFUSIONS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 48. GLOBAL HERBAL MEDICINE MARKET SIZE, BY TEAS & INFUSIONS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 49. GLOBAL HERBAL MEDICINE MARKET SIZE, BY BOTANICAL ORIGIN, 2018-2024 (USD MILLION)
• TABLE 50. GLOBAL HERBAL MEDICINE MARKET SIZE, BY BOTANICAL ORIGIN, 2025-2032 (USD MILLION)
• TABLE 51. GLOBAL HERBAL MEDICINE MARKET SIZE, BY BARK, BY REGION, 2018-2024 (USD MILLION)
• TABLE 52. GLOBAL HERBAL MEDICINE MARKET SIZE, BY BARK, BY REGION, 2025-2032 (USD MILLION)
• TABLE 53. GLOBAL HERBAL MEDICINE MARKET SIZE, BY BARK, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 54. GLOBAL HERBAL MEDICINE MARKET SIZE, BY BARK, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 55. GLOBAL HERBAL MEDICINE MARKET SIZE, BY BARK, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 56. GLOBAL HERBAL MEDICINE MARKET SIZE, BY BARK, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 57. GLOBAL HERBAL MEDICINE MARKET SIZE, BY FLOWERS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 58. GLOBAL HERBAL MEDICINE MARKET SIZE, BY FLOWERS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 59. GLOBAL HERBAL MEDICINE MARKET SIZE, BY FLOWERS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 60. GLOBAL HERBAL MEDICINE MARKET SIZE, BY FLOWERS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 61. GLOBAL HERBAL MEDICINE MARKET SIZE, BY FLOWERS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 62. GLOBAL HERBAL MEDICINE MARKET SIZE, BY FLOWERS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 63. GLOBAL HERBAL MEDICINE MARKET SIZE, BY FRUITS & SEEDS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 64. GLOBAL HERBAL MEDICINE MARKET SIZE, BY FRUITS & SEEDS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 65. GLOBAL HERBAL MEDICINE MARKET SIZE, BY FRUITS & SEEDS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 66. GLOBAL HERBAL MEDICINE MARKET SIZE, BY FRUITS & SEEDS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 67. GLOBAL HERBAL MEDICINE MARKET SIZE, BY FRUITS & SEEDS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 68. GLOBAL HERBAL MEDICINE MARKET SIZE, BY FRUITS & SEEDS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 69. GLOBAL HERBAL MEDICINE MARKET SIZE, BY LEAVES, BY REGION, 2018-2024 (USD MILLION)
• TABLE 70. GLOBAL HERBAL MEDICINE MARKET SIZE, BY LEAVES, BY REGION, 2025-2032 (USD MILLION)
• TABLE 71. GLOBAL HERBAL MEDICINE MARKET SIZE, BY LEAVES, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 72. GLOBAL HERBAL MEDICINE MARKET SIZE, BY LEAVES, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 73. GLOBAL HERBAL MEDICINE MARKET SIZE, BY LEAVES, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 74. GLOBAL HERBAL MEDICINE MARKET SIZE, BY LEAVES, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 75. GLOBAL HERBAL MEDICINE MARKET SIZE, BY ROOTS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 76. GLOBAL HERBAL MEDICINE MARKET SIZE, BY ROOTS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 77. GLOBAL HERBAL MEDICINE MARKET SIZE, BY ROOTS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 78. GLOBAL HERBAL MEDICINE MARKET SIZE, BY ROOTS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 79. GLOBAL HERBAL MEDICINE MARKET SIZE, BY ROOTS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 80. GLOBAL HERBAL MEDICINE MARKET SIZE, BY ROOTS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 81. GLOBAL HERBAL MEDICINE MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
• TABLE 82. GLOBAL HERBAL MEDICINE MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
• TABLE 83. GLOBAL HERBAL MEDICINE MARKET SIZE, BY HERBAL BEAUTY PRODUCTS / COSMETICS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 84. GLOBAL HERBAL MEDICINE MARKET SIZE, BY HERBAL BEAUTY PRODUCTS / COSMETICS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 85. GLOBAL HERBAL MEDICINE MARKET SIZE, BY HERBAL BEAUTY PRODUCTS / COSMETICS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 86. GLOBAL HERBAL MEDICINE MARKET SIZE, BY HERBAL BEAUTY PRODUCTS / COSMETICS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 87. GLOBAL HERBAL MEDICINE MARKET SIZE, BY HERBAL BEAUTY PRODUCTS / COSMETICS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 88. GLOBAL HERBAL MEDICINE MARKET SIZE, BY HERBAL BEAUTY PRODUCTS / COSMETICS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 89. GLOBAL HERBAL MEDICINE MARKET SIZE, BY HERBAL DIETARY SUPPLEMENTS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 90. GLOBAL HERBAL MEDICINE MARKET SIZE, BY HERBAL DIETARY SUPPLEMENTS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 91. GLOBAL HERBAL MEDICINE MARKET SIZE, BY HERBAL DIETARY SUPPLEMENTS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 92. GLOBAL HERBAL MEDICINE MARKET SIZE, BY HERBAL DIETARY SUPPLEMENTS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 93. GLOBAL HERBAL MEDICINE MARKET SIZE, BY HERBAL DIETARY SUPPLEMENTS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 94. GLOBAL HERBAL MEDICINE MARKET SIZE, BY HERBAL DIETARY SUPPLEMENTS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 95. GLOBAL HERBAL MEDICINE MARKET SIZE, BY HERBAL FUNCTIONAL FOODS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 96. GLOBAL HERBAL MEDICINE MARKET SIZE, BY HERBAL FUNCTIONAL FOODS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 97. GLOBAL HERBAL MEDICINE MARKET SIZE, BY HERBAL FUNCTIONAL FOODS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 98. GLOBAL HERBAL MEDICINE MARKET SIZE, BY HERBAL FUNCTIONAL FOODS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 99. GLOBAL HERBAL MEDICINE MARKET SIZE, BY HERBAL FUNCTIONAL FOODS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 100. GLOBAL HERBAL MEDICINE MARKET SIZE, BY HERBAL FUNCTIONAL FOODS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 101. GLOBAL HERBAL MEDICINE MARKET SIZE, BY HERBAL PHARMACEUTICAL PRODUCTS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 102. GLOBAL HERBAL MEDICINE MARKET SIZE, BY HERBAL PHARMACEUTICAL PRODUCTS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 103. GLOBAL HERBAL MEDICINE MARKET SIZE, BY HERBAL PHARMACEUTICAL PRODUCTS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 104. GLOBAL HERBAL MEDICINE MARKET SIZE, BY HERBAL PHARMACEUTICAL PRODUCTS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 105. GLOBAL HERBAL MEDICINE MARKET SIZE, BY HERBAL PHARMACEUTICAL PRODUCTS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 106. GLOBAL HERBAL MEDICINE MARKET SIZE, BY HERBAL PHARMACEUTICAL PRODUCTS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 107. GLOBAL HERBAL MEDICINE MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
• TABLE 108. GLOBAL HERBAL MEDICINE MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
• TABLE 109. GLOBAL HERBAL MEDICINE MARKET SIZE, BY CARDIOVASCULAR HEALTH, BY REGION, 2018-2024 (USD MILLION)
• TABLE 110. GLOBAL HERBAL MEDICINE MARKET SIZE, BY CARDIOVASCULAR HEALTH, BY REGION, 2025-2032 (USD MILLION)
• TABLE 111. GLOBAL HERBAL MEDICINE MARKET SIZE, BY CARDIOVASCULAR HEALTH, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 112. GLOBAL HERBAL MEDICINE MARKET SIZE, BY CARDIOVASCULAR HEALTH, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 113. GLOBAL HERBAL MEDICINE MARKET SIZE, BY CARDIOVASCULAR HEALTH, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 114. GLOBAL HERBAL MEDICINE MARKET SIZE, BY CARDIOVASCULAR HEALTH, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 115. GLOBAL HERBAL MEDICINE MARKET SIZE, BY DIGESTIVE DISORDERS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 116. GLOBAL HERBAL MEDICINE MARKET SIZE, BY DIGESTIVE DISORDERS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 117. GLOBAL HERBAL MEDICINE MARKET SIZE, BY DIGESTIVE DISORDERS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 118. GLOBAL HERBAL MEDICINE MARKET SIZE, BY DIGESTIVE DISORDERS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 119. GLOBAL HERBAL MEDICINE MARKET SIZE, BY DIGESTIVE DISORDERS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 120. GLOBAL HERBAL MEDICINE MARKET SIZE, BY DIGESTIVE DISORDERS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 121. GLOBAL HERBAL MEDICINE MARKET SIZE, BY GENERAL WELLNESS & IMMUNITY BOOSTING, BY REGION, 2018-2024 (USD MILLION)
• TABLE 122. GLOBAL HERBAL MEDICINE MARKET SIZE, BY GENERAL WELLNESS & IMMUNITY BOOSTING, BY REGION, 2025-2032 (USD MILLION)
• TABLE 123. GLOBAL HERBAL MEDICINE MARKET SIZE, BY GENERAL WELLNESS & IMMUNITY BOOSTING, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 124. GLOBAL HERBAL MEDICINE MARKET SIZE, BY GENERAL WELLNESS & IMMUNITY BOOSTING, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 125. GLOBAL HERBAL MEDICINE MARKET SIZE, BY GENERAL WELLNESS & IMMUNITY BOOSTING, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 126. GLOBAL HERBAL MEDICINE MARKET SIZE, BY GENERAL WELLNESS & IMMUNITY BOOSTING, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 127. GLOBAL HERBAL MEDICINE MARKET SIZE, BY LIVER & KIDNEY DISORDERS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 128. GLOBAL HERBAL MEDICINE MARKET SIZE, BY LIVER & KIDNEY DISORDERS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 129. GLOBAL HERBAL MEDICINE MARKET SIZE, BY LIVER & KIDNEY DISORDERS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 130. GLOBAL HERBAL MEDICINE MARKET SIZE, BY LIVER & KIDNEY DISORDERS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 131. GLOBAL HERBAL MEDICINE MARKET SIZE, BY LIVER & KIDNEY DISORDERS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 132. GLOBAL HERBAL MEDICINE MARKET SIZE, BY LIVER & KIDNEY DISORDERS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 133. GLOBAL HERBAL MEDICINE MARKET SIZE, BY MENTAL HEALTH, BY REGION, 2018-2024 (USD MILLION)
• TABLE 134. GLOBAL HERBAL MEDICINE MARKET SIZE, BY MENTAL HEALTH, BY REGION, 2025-2032 (USD MILLION)
• TABLE 135. GLOBAL HERBAL MEDICINE MARKET SIZE, BY MENTAL HEALTH, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 136. GLOBAL HERBAL MEDICINE MARKET SIZE, BY MENTAL HEALTH, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 137. GLOBAL HERBAL MEDICINE MARKET SIZE, BY MENTAL HEALTH, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 138. GLOBAL HERBAL MEDICINE MARKET SIZE, BY MENTAL HEALTH, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 139. GLOBAL HERBAL MEDICINE MARKET SIZE, BY RESPIRATORY CONDITIONS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 140. GLOBAL HERBAL MEDICINE MARKET SIZE, BY RESPIRATORY CONDITIONS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 141. GLOBAL HERBAL MEDICINE MARKET SIZE, BY RESPIRATORY CONDITIONS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 142. GLOBAL HERBAL MEDICINE MARKET SIZE, BY RESPIRATORY CONDITIONS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 143. GLOBAL HERBAL MEDICINE MARKET SIZE, BY RESPIRATORY CONDITIONS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 144. GLOBAL HERBAL MEDICINE MARKET SIZE, BY RESPIRATORY CONDITIONS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 145. GLOBAL HERBAL MEDICINE MARKET SIZE, BY SEXUAL HEALTH & REPRODUCTIVE ISSUES, BY REGION, 2018-2024 (USD MILLION)
• TABLE 146. GLOBAL HERBAL MEDICINE MARKET SIZE, BY SEXUAL HEALTH & REPRODUCTIVE ISSUES, BY REGION, 2025-2032 (USD MILLION)
• TABLE 147. GLOBAL HERBAL MEDICINE MARKET SIZE, BY SEXUAL HEALTH & REPRODUCTIVE ISSUES, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 148. GLOBAL HERBAL MEDICINE MARKET SIZE, BY SEXUAL HEALTH & REPRODUCTIVE ISSUES, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 149. GLOBAL HERBAL MEDICINE MARKET SIZE, BY SEXUAL HEALTH & REPRODUCTIVE ISSUES, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 150. GLOBAL HERBAL MEDICINE MARKET SIZE, BY SEXUAL HEALTH & REPRODUCTIVE ISSUES, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 151. GLOBAL HERBAL MEDICINE MARKET SIZE, BY SKIN DISORDERS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 152. GLOBAL HERBAL MEDICINE MARKET SIZE, BY SKIN DISORDERS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 153. GLOBAL HERBAL MEDICINE MARKET SIZE, BY SKIN DISORDERS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 154. GLOBAL HERBAL MEDICINE MARKET SIZE, BY SKIN DISORDERS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 155. GLOBAL HERBAL MEDICINE MARKET SIZE, BY SKIN DISORDERS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 156. GLOBAL HERBAL MEDICINE MARKET SIZE, BY SKIN DISORDERS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 157. GLOBAL HERBAL MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
• TABLE 158. GLOBAL HERBAL MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
• TABLE 159. GLOBAL HERBAL MEDICINE MARKET SIZE, BY AYURVEDIC CLINICS & TRADITIONAL HEALERS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 160. GLOBAL HERBAL MEDICINE MARKET SIZE, BY AYURVEDIC CLINICS & TRADITIONAL HEALERS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 161. GLOBAL HERBAL MEDICINE MARKET SIZE, BY AYURVEDIC CLINICS & TRADITIONAL HEALERS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 162. GLOBAL HERBAL MEDICINE MARKET SIZE, BY AYURVEDIC CLINICS & TRADITIONAL HEALERS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 163. GLOBAL HERBAL MEDICINE MARKET SIZE, BY AYURVEDIC CLINICS & TRADITIONAL HEALERS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 164. GLOBAL HERBAL MEDICINE MARKET SIZE, BY AYURVEDIC CLINICS & TRADITIONAL HEALERS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 165. GLOBAL HERBAL MEDICINE MARKET SIZE, BY DIRECT SELLING, BY REGION, 2018-2024 (USD MILLION)
• TABLE 166. GLOBAL HERBAL MEDICINE MARKET SIZE, BY DIRECT SELLING, BY REGION, 2025-2032 (USD MILLION)
• TABLE 167. GLOBAL HERBAL MEDICINE MARKET SIZE, BY DIRECT SELLING, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 168. GLOBAL HERBAL MEDICINE MARKET SIZE, BY DIRECT SELLING, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 169. GLOBAL HERBAL MEDICINE MARKET SIZE, BY DIRECT SELLING, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 170. GLOBAL HERBAL MEDICINE MARKET SIZE, BY DIRECT SELLING, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 171. GLOBAL HERBAL MEDICINE MARKET SIZE, BY HEALTH & WELLNESS STORES, BY REGION, 2018-2024 (USD MILLION)
• TABLE 172. GLOBAL HERBAL MEDICINE MARKET SIZE, BY HEALTH & WELLNESS STORES, BY REGION, 2025-2032 (USD MILLION)
• TABLE 173. GLOBAL HERBAL MEDICINE MARKET SIZE, BY HEALTH & WELLNESS STORES, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 174. GLOBAL HERBAL MEDICINE MARKET SIZE, BY HEALTH & WELLNESS STORES, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 175. GLOBAL HERBAL MEDICINE MARKET SIZE, BY HEALTH & WELLNESS STORES, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 176. GLOBAL HERBAL MEDICINE MARKET SIZE, BY HEALTH & WELLNESS STORES, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 177. GLOBAL HERBAL MEDICINE MARKET SIZE, BY HOSPITAL & RETAIL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
• TABLE 178. GLOBAL HERBAL MEDICINE MARKET SIZE, BY HOSPITAL & RETAIL PHARMACIES, BY REGION, 2025-2032 (USD MILLION)
• TABLE 179. GLOBAL HERBAL MEDICINE MARKET SIZE, BY HOSPITAL & RETAIL PHARMACIES, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 180. GLOBAL HERBAL MEDICINE MARKET SIZE, BY HOSPITAL & RETAIL PHARMACIES, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 181. GLOBAL HERBAL MEDICINE MARKET SIZE, BY HOSPITAL & RETAIL PHARMACIES, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 182. GLOBAL HERBAL MEDICINE MARKET SIZE, BY HOSPITAL & RETAIL PHARMACIES, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 183. GLOBAL HERBAL MEDICINE MARKET SIZE, BY ONLINE PHARMACIES / E-COMMERCE, BY REGION, 2018-2024 (USD MILLION)
• TABLE 184. GLOBAL HERBAL MEDICINE MARKET SIZE, BY ONLINE PHARMACIES / E-COMMERCE, BY REGION, 2025-2032 (USD MILLION)
• TABLE 185. GLOBAL HERBAL MEDICINE MARKET SIZE, BY ONLINE PHARMACIES / E-COMMERCE, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 186. GLOBAL HERBAL MEDICINE MARKET SIZE, BY ONLINE PHARMACIES / E-COMMERCE, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 187. GLOBAL HERBAL MEDICINE MARKET SIZE, BY ONLINE PHARMACIES / E-COMMERCE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 188. GLOBAL HERBAL MEDICINE MARKET SIZE, BY ONLINE PHARMACIES / E-COMMERCE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 189. GLOBAL HERBAL MEDICINE MARKET SIZE, BY SUPERMARKETS / HYPERMARKETS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 190. GLOBAL HERBAL MEDICINE MARKET SIZE, BY SUPERMARKETS / HYPERMARKETS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 191. GLOBAL HERBAL MEDICINE MARKET SIZE, BY SUPERMARKETS / HYPERMARKETS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 192. GLOBAL HERBAL MEDICINE MARKET SIZE, BY SUPERMARKETS / HYPERMARKETS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 193. GLOBAL HERBAL MEDICINE MARKET SIZE, BY SUPERMARKETS / HYPERMARKETS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 194. GLOBAL HERBAL MEDICINE MARKET SIZE, BY SUPERMARKETS / HYPERMARKETS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 195. GLOBAL HERBAL MEDICINE MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
• TABLE 196. GLOBAL HERBAL MEDICINE MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
• TABLE 197. AMERICAS HERBAL MEDICINE MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
• TABLE 198. AMERICAS HERBAL MEDICINE MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
• TABLE 199. AMERICAS HERBAL MEDICINE MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
• TABLE 200. AMERICAS HERBAL MEDICINE MARKET SIZE, BY FORM, 2025-2032 (USD MILLION)
• TABLE 201. AMERICAS HERBAL MEDICINE MARKET SIZE, BY BOTANICAL ORIGIN, 2018-2024 (USD MILLION)
• TABLE 202. AMERICAS HERBAL MEDICINE MARKET SIZE, BY BOTANICAL ORIGIN, 2025-2032 (USD MILLION)
• TABLE 203. AMERICAS HERBAL MEDICINE MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
• TABLE 204. AMERICAS HERBAL MEDICINE MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
• TABLE 205. AMERICAS HERBAL MEDICINE MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
• TABLE 206. AMERICAS HERBAL MEDICINE MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
• TABLE 207. AMERICAS HERBAL MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
• TABLE 208. AMERICAS HERBAL MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
• TABLE 209. NORTH AMERICA HERBAL MEDICINE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 210. NORTH AMERICA HERBAL MEDICINE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 211. NORTH AMERICA HERBAL MEDICINE MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
• TABLE 212. NORTH AMERICA HERBAL MEDICINE MARKET SIZE, BY FORM, 2025-2032 (USD MILLION)
• TABLE 213. NORTH AMERICA HERBAL MEDICINE MARKET SIZE, BY BOTANICAL ORIGIN, 2018-2024 (USD MILLION)
• TABLE 214. NORTH AMERICA HERBAL MEDICINE MARKET SIZE, BY BOTANICAL ORIGIN, 2025-2032 (USD MILLION)
• TABLE 215. NORTH AMERICA HERBAL MEDICINE MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
• TABLE 216. NORTH AMERICA HERBAL MEDICINE MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
• TABLE 217. NORTH AMERICA HERBAL MEDICINE MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
• TABLE 218. NORTH AMERICA HERBAL MEDICINE MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
• TABLE 219. NORTH AMERICA HERBAL MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
• TABLE 220. NORTH AMERICA HERBAL MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
• TABLE 221. LATIN AMERICA HERBAL MEDICINE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 222. LATIN AMERICA HERBAL MEDICINE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 223. LATIN AMERICA HERBAL MEDICINE MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
• TABLE 224. LATIN AMERICA HERBAL MEDICINE MARKET SIZE, BY FORM, 2025-2032 (USD MILLION)
• TABLE 225. LATIN AMERICA HERBAL MEDICINE MARKET SIZE, BY BOTANICAL ORIGIN, 2018-2024 (USD MILLION)
• TABLE 226. LATIN AMERICA HERBAL MEDICINE MARKET SIZE, BY BOTANICAL ORIGIN, 2025-2032 (USD MILLION)
• TABLE 227. LATIN AMERICA HERBAL MEDICINE MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
• TABLE 228. LATIN AMERICA HERBAL MEDICINE MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
• TABLE 229. LATIN AMERICA HERBAL MEDICINE MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
• TABLE 230. LATIN AMERICA HERBAL MEDICINE MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
• TABLE 231. LATIN AMERICA HERBAL MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
• TABLE 232. LATIN AMERICA HERBAL MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
• TABLE 233. EUROPE, MIDDLE EAST & AFRICA HERBAL MEDICINE MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
• TABLE 234. EUROPE, MIDDLE EAST & AFRICA HERBAL MEDICINE MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
• TABLE 235. EUROPE, MIDDLE EAST & AFRICA HERBAL MEDICINE MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
• TABLE 236. EUROPE, MIDDLE EAST & AFRICA HERBAL MEDICINE MARKET SIZE, BY FORM, 2025-2032 (USD MILLION)
• TABLE 237. EUROPE, MIDDLE EAST & AFRICA HERBAL MEDICINE MARKET SIZE, BY BOTANICAL ORIGIN, 2018-2024 (USD MILLION)
• TABLE 238. EUROPE, MIDDLE EAST & AFRICA HERBAL MEDICINE MARKET SIZE, BY BOTANICAL ORIGIN, 2025-2032 (USD MILLION)
• TABLE 239. EUROPE, MIDDLE EAST & AFRICA HERBAL MEDICINE MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
• TABLE 240. EUROPE, MIDDLE EAST & AFRICA HERBAL MEDICINE MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
• TABLE 241. EUROPE, MIDDLE EAST & AFRICA HERBAL MEDICINE MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
• TABLE 242. EUROPE, MIDDLE EAST & AFRICA HERBAL MEDICINE MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
• TABLE 243. EUROPE, MIDDLE EAST & AFRICA HERBAL MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
• TABLE 244. EUROPE, MIDDLE EAST & AFRICA HERBAL MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
• TABLE 245. EUROPE HERBAL MEDICINE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 246. EUROPE HERBAL MEDICINE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 247. EUROPE HERBAL MEDICINE MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
• TABLE 248. EUROPE HERBAL MEDICINE MARKET SIZE, BY FORM, 2025-2032 (USD MILLION)
• TABLE 249. EUROPE HERBAL MEDICINE MARKET SIZE, BY BOTANICAL ORIGIN, 2018-2024 (USD MILLION)
• TABLE 250. EUROPE HERBAL MEDICINE MARKET SIZE, BY BOTANICAL ORIGIN, 2025-2032 (USD MILLION)
• TABLE 251. EUROPE HERBAL MEDICINE MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
• TABLE 252. EUROPE HERBAL MEDICINE MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
• TABLE 253. EUROPE HERBAL MEDICINE MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
• TABLE 254. EUROPE HERBAL MEDICINE MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
• TABLE 255. EUROPE HERBAL MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
• TABLE 256. EUROPE HERBAL MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
• TABLE 257. MIDDLE EAST HERBAL MEDICINE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 258. MIDDLE EAST HERBAL MEDICINE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 259. MIDDLE EAST HERBAL MEDICINE MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
• TABLE 260. MIDDLE EAST HERBAL MEDICINE MARKET SIZE, BY FORM, 2025-2032 (USD MILLION)
• TABLE 261. MIDDLE EAST HERBAL MEDICINE MARKET SIZE, BY BOTANICAL ORIGIN, 2018-2024 (USD MILLION)
• TABLE 262. MIDDLE EAST HERBAL MEDICINE MARKET SIZE, BY BOTANICAL ORIGIN, 2025-2032 (USD MILLION)
• TABLE 263. MIDDLE EAST HERBAL MEDICINE MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
• TABLE 264. MIDDLE EAST HERBAL MEDICINE MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
• TABLE 265. MIDDLE EAST HERBAL MEDICINE MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
• TABLE 266. MIDDLE EAST HERBAL MEDICINE MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
• TABLE 267. MIDDLE EAST HERBAL MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
• TABLE 268. MIDDLE EAST HERBAL MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
• TABLE 269. AFRICA HERBAL MEDICINE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 270. AFRICA HERBAL MEDICINE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 271. AFRICA HERBAL MEDICINE MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
• TABLE 272. AFRICA HERBAL MEDICINE MARKET SIZE, BY FORM, 2025-2032 (USD MILLION)
• TABLE 273. AFRICA HERBAL MEDICINE MARKET SIZE, BY BOTANICAL ORIGIN, 2018-2024 (USD MILLION)
• TABLE 274. AFRICA HERBAL MEDICINE MARKET SIZE, BY BOTANICAL ORIGIN, 2025-2032 (USD MILLION)
• TABLE 275. AFRICA HERBAL MEDICINE MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
• TABLE 276. AFRICA HERBAL MEDICINE MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
• TABLE 277. AFRICA HERBAL MEDICINE MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
• TABLE 278. AFRICA HERBAL MEDICINE MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
• TABLE 279. AFRICA HERBAL MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
• TABLE 280. AFRICA HERBAL MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
• TABLE 281. ASIA-PACIFIC HERBAL MEDICINE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 282. ASIA-PACIFIC HERBAL MEDICINE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 283. ASIA-PACIFIC HERBAL MEDICINE MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
• TABLE 284. ASIA-PACIFIC HERBAL MEDICINE MARKET SIZE, BY FORM, 2025-2032 (USD MILLION)
• TABLE 285. ASIA-PACIFIC HERBAL MEDICINE MARKET SIZE, BY BOTANICAL ORIGIN, 2018-2024 (USD MILLION)
• TABLE 286. ASIA-PACIFIC HERBAL MEDICINE MARKET SIZE, BY BOTANICAL ORIGIN, 2025-2032 (USD MILLION)
• TABLE 287. ASIA-PACIFIC HERBAL MEDICINE MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
• TABLE 288. ASIA-PACIFIC HERBAL MEDICINE MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
• TABLE 289. ASIA-PACIFIC HERBAL MEDICINE MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
• TABLE 290. ASIA-PACIFIC HERBAL MEDICINE MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
• TABLE 291. ASIA-PACIFIC HERBAL MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
• TABLE 292. ASIA-PACIFIC HERBAL MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
• TABLE 293. GLOBAL HERBAL MEDICINE MARKET SIZE, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 294. GLOBAL HERBAL MEDICINE MARKET SIZE, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 295. ASEAN HERBAL MEDICINE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 296. ASEAN HERBAL MEDICINE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 297. ASEAN HERBAL MEDICINE MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
• TABLE 298. ASEAN HERBAL MEDICINE MARKET SIZE, BY FORM, 2025-2032 (USD MILLION)
• TABLE 299. ASEAN HERBAL MEDICINE MARKET SIZE, BY BOTANICAL ORIGIN, 2018-2024 (USD MILLION)
• TABLE 300. ASEAN HERBAL MEDICINE MARKET SIZE, BY BOTANICAL ORIGIN, 2025-2032 (USD MILLION)
• TABLE 301. ASEAN HERBAL MEDICINE MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
• TABLE 302. ASEAN HERBAL MEDICINE MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
• TABLE 303. ASEAN HERBAL MEDICINE MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
• TABLE 304. ASEAN HERBAL MEDICINE MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
• TABLE 305. ASEAN HERBAL MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
• TABLE 306. ASEAN HERBAL MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
• TABLE 307. GCC HERBAL MEDICINE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 308. GCC HERBAL MEDICINE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 309. GCC HERBAL MEDICINE MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
• TABLE 310. GCC HERBAL MEDICINE MARKET SIZE, BY FORM, 2025-2032 (USD MILLION)
• TABLE 311. GCC HERBAL MEDICINE MARKET SIZE, BY BOTANICAL ORIGIN, 2018-2024 (USD MILLION)
• TABLE 312. GCC HERBAL MEDICINE MARKET SIZE, BY BOTANICAL ORIGIN, 2025-2032 (USD MILLION)
• TABLE 313. GCC HERBAL MEDICINE MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
• TABLE 314. GCC HERBAL MEDICINE MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
• TABLE 315. GCC HERBAL MEDICINE MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
• TABLE 316. GCC HERBAL MEDICINE MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
• TABLE 317. GCC HERBAL MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
• TABLE 318. GCC HERBAL MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
• TABLE 319. EUROPEAN UNION HERBAL MEDICINE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 320. EUROPEAN UNION HERBAL MEDICINE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 321. EUROPEAN UNION HERBAL MEDICINE MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
• TABLE 322. EUROPEAN UNION HERBAL MEDICINE MARKET SIZE, BY FORM, 2025-2032 (USD MILLION)
• TABLE 323. EUROPEAN UNION HERBAL MEDICINE MARKET SIZE, BY BOTANICAL ORIGIN, 2018-2024 (USD MILLION)
• TABLE 324. EUROPEAN UNION HERBAL MEDICINE MARKET SIZE, BY BOTANICAL ORIGIN, 2025-2032 (USD MILLION)
• TABLE 325. EUROPEAN UNION HERBAL MEDICINE MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
• TABLE 326. EUROPEAN UNION HERBAL MEDICINE MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
• TABLE 327. EUROPEAN UNION HERBAL MEDICINE MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
• TABLE 328. EUROPEAN UNION HERBAL MEDICINE MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
• TABLE 329. EUROPEAN UNION HERBAL MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
• TABLE 330. EUROPEAN UNION HERBAL MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
• TABLE 331. BRICS HERBAL MEDICINE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 332. BRICS HERBAL MEDICINE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 333. BRICS HERBAL MEDICINE MARKET SIZE,